☰

Jing Sun, Ph.D.

Affiliations: 
2010 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Pharmacy, Pharmaceutical Chemistry
Google:
"Jing Sun"
Mean distance: 3619.36
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Gordon L. Amidon grad student 2010 University of Michigan
 (Intestinal absorption of low permeability drugs: A transporter- and enzyme-targeted approach.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Xu JB, Guan WJ, Zhang YL, et al. (2024) SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl concentration. Signal Transduction and Targeted Therapy. 9: 74
Walker J, Albert J, Liang D, et al. (2022) In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery. Drug Delivery and Translational Research
Sun J, Walker J, Beck-Broichsitter M, et al. (2021) Correction to: Characterization of commercial PLGAs by NMR spectroscopy. Drug Delivery and Translational Research
Sun J, Walker J, Beck-Broichsitter M, et al. (2021) Characterization of commercial PLGAs by NMR spectroscopy. Drug Delivery and Translational Research
Sun J, Hong Z, Shao S, et al. (2021) Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo. Toxicology and Applied Pharmacology. 115617
Fu J, Zheng H, Cui Q, et al. (2017) Nfe2l1 silenced insulinoma cells acquire aggressiveness and chemo-resistance. Endocrine-Related Cancer
Cui Q, Fu J, Hu Y, et al. (2017) Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity. Toxicology and Applied Pharmacology
Incecayir T, Sun J, Tsume Y, et al. (2016) Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. Journal of Pharmaceutical Sciences. 105: 925-34
Sabit H, Dahan A, Sun J, et al. (2013) Cytomegalovirus protease targeted prodrug development. Molecular Pharmaceutics. 10: 1417-24
Gupta SV, Gupta D, Sun J, et al. (2011) Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach. Molecular Pharmaceutics. 8: 2358-67
See more...